Role of the molecular staging and response in the management of follicular lymphoma patients

Leukemia and Lymphoma

Volumn 47, Issue 6, 2006, Pages 1018-1022

  Arcaini, Luca ^a   Colombo, Nora ^a   Bernasconi, Paolo ^a   Calatroni, Silvia ^a   Passamonti, Francesco ^a   Orlandi, Ester ^a   Bonfichi, Maurizio ^a   Burcheri, Sara ^a   Della Porta, Matteo ^a   Rumi, Elisa ^a   Montanari, Francesca ^a   Algarotti, Alessandra ^a   Pascutto, Cristiana ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

bcl 2; Follicular lymphoma; Molecular response; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN HEAVY CHAIN; LACTATE DEHYDROGENASE; PREDNISONE; PROTEIN BCL 2; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; BONE MARROW CELLS; DISEASE-FREE SURVIVAL; FEMALE; GENE REARRANGEMENT; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 33746298094     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500467834     Document Type: Article

References (18)

1. Horning, S. (1993) Natural history of and therapy for the indolent non-Hodgkin's lymphomas Semin Oncol, 20(Suppl 5), pp. 75-88.
2. Weiss, L and Warnke, R and Sklar, J and Cleary, M. (1987) Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas N Engl J Med, 317, pp. 1185-1189.
3. Lopez-Guillermo, A and Cabanillas, F and McDonnell, T and McLaughlin, P and Smith, T and Pugh, W and et al. (1999) Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma Blood, 93, pp. 3081-3087.
4. Pezzella, F and Jones, M and Ralfkiaer, E and Ersboll, J and Gatter, K and Mason, D. (1992) Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma Br J Cancer, 65, pp. 87-89.
5. Montoto, S and Lopez-Guillermo, A and Colomer, D and Esteve, J and Bosch, F and Ferrer, A and et al. (2003) Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma Leuk Lymphoma, 44, pp. 71-76.
6. Rambaldi, A and Lazzari, M and Manzoni, C and Carlotti, E and Arcaini, L and Baccarani, M and et al. (2002) Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma Blood, 99, pp. 856-862.
7. Freedman, A and Neuberg, D and Mauch, P and Soiffer, R and Anderson, K and Fisher, D and et al. (1999) Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma Blood, 94, pp. 3325-3333.
8. Apostolidis, J and Gupta, R and Grenzelias, D and Johnson, P and Pappa, V and Summers, K and et al. (2000) High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up J Clin Oncol, 18, pp. 527-536.
9. Magni, M and Di Nicola, M and Devizzi, L and Matteucci, P and Lombardi, F and Gandola, L and et al. (2000) Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: Evidence for a role of both chemotherapy and rituximab infusion Blood, 96, pp. 864-869.
10. Lazzarino, M and Arcaini, L and Bernasconi, P and Alessandrino, E and Gargantini, L and Cairoli, R and et al. (2002) A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma Br J Haematol, 116, pp. 229-235.
11. Voso, M and Pantel, G and Weis, M and Schmidt, P and Martin, S and Moos, M and Ho, A and Haas, R and Hohaus, S. (2000) In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma Br J Haematol, 109, pp. 729-735.
12. Horsman, D and Gascoyne, R and Coupland, R and Coldman, A and Adomat, S. (1995) Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma Am J Clin Pathol, 103, pp. 472-478.
13. Seite, P and Hillion, J and d'Agay, M and Gaulard, P and Cazals, D and Badoux, F and et al. (1993) BCL2 gene activation and protein expression in follicular lymphoma: A report on 64 cases Leukemia, 7, pp. 410-417.
14. Colombat, P and Salles, G and Brousse, N and Eftekhari, P and Soubeyran, P and Delwail, V and et al. (2001) Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: Clinical and molecular evaluation Blood, 97, pp. 101-106.
15. Johnson, A and Brun, A and Dictor, M and Rambech, E and Akerman, M and Anderson, H. (1995) Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade A report from southern Sweden. Ann Oncol, 6, pp. 789-794.
16. Yunis, J and Mayer, M and Arnesen, M and Aeppli, D and Oken, M and Frizzera, G. (1989) bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma N Engl J Med, 320, pp. 1047-1054.
17. Gribben, J and Neuberg, D and Barber, M and Moore, J and Pesek, K and Freedman, A and et al. (1994) Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow Blood, 83, pp. 3800-3807.
18. Lopez-Guillermo, A and Cabanillas, F and McLaughlin, P and Smith, T and Hagemeister, F and Rodriguez, M and et al. (1998) The clinical significance of molecular response in indolent follicular lymphomas Blood, 91, pp. 2955-2960.